Product Information
TOPIRAMATE ER 200 MG CAPSULE is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $23.1283 per EA under NDC 00480235901. Its NADAC has been published 166 times since Jun 21, 2023.
FDA first approved this application on Mar 10, 2023. Its Orange Book therapeutic-equivalence code is AB1 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
200 mg/1
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00480235901
Classification
Generic
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
TOPIRAMATEApproval Type
Generic (ANDA)
FDA Application
ANDA206210FDA Approved
3/10/2023
TE Code
AB1
On Market Since
3/31/2023
Pharmacological Classes
Price Statistics
The NADAC for TOPIRAMATE ER 200 MG CAPSULE has been published 166 times since Jun 21, 2023, and over the history we have for it it has declined 31.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $23.1283 per EA |
|---|---|
| All-time high | $34.7626 (Jan 10, 2024) |
| All-time low | $18.7572 (Jul 17, 2024) |
| 52-week high | $25.8176 |
| 52-week low | $22.2272 |
| Median price | $25.4775 |
| Average price | $26.4902 |
| Largest weekly change | +22.6% (Nov 22, 2023) |
| Weeks tracked | 166 |
| Tracking since | Jun 21, 2023 |
Generic Alternatives
The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 58% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of TOPIRAMATE ER 200 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for TOPIRAMATE ER 200 MG CAPSULE, manufactured by Teva Pharmaceuticals USA Inc., is $23.1283 per EA (NDC 00480235901), effective Aug 19, 2026.
How has the price of TOPIRAMATE ER 200 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for TOPIRAMATE ER 200 MG CAPSULE has declined 31.6%. It has been tracked across 166 weekly CMS publications since Jun 21, 2023.
What are the highest and lowest recorded NADAC prices for TOPIRAMATE ER 200 MG CAPSULE?
Since Jun 21, 2023, the NADAC for TOPIRAMATE ER 200 MG CAPSULE has ranged from a low of $18.7572 (Jul 17, 2024) to a high of $34.7626 (Jan 10, 2024), with a median of $25.4775 per EA.
Are there cheaper alternatives to TOPIRAMATE ER 200 MG CAPSULE?
Yes. 6 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, TOPIRAMATE ER 200 MG SPRINK CAP, is $9.6713 per EA — about 58% below TOPIRAMATE ER 200 MG CAPSULE.
Who manufactures TOPIRAMATE ER 200 MG CAPSULE?
TOPIRAMATE ER 200 MG CAPSULE (NDC 00480235901) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.